Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Klotho Neurosciences, Inc. (KLTO) had Weighted-Average Shares Outstanding (Diluted) of 27.52M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-2.23M |
|
-- |
|
-- |
|
$1.59M |
|
$-1.59M |
|
$-0.65M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-1.59M |
|
$-1.59M |
|
27.52M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
27.52M |
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$0.69M |
|
-- |
|
$2.30M |
|
$2.99M |
|
$2.34M |
|
-- |
|
$0.01M |
|
$2.35M |
|
$0.64M |
|
$-1.66M |
|
$0.64M |
|
28.51M |
|
| Cash Flow Statement Financials | |
$-1.55M |
|
-- |
|
$2.06M |
|
$0.06M |
|
$0.57M |
|
$0.50M |
|
$0.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.29 |
|
-- |
|
-- |
|
-- |
|
2.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-349.77% |
|
134.51% |
|
-74.78% |
|
-349.77% |
|
$0.02 |
|
$-0.06 |
|
$-0.06 |
|